U.S. Transdermal Skin Patches Market Size & Outlook
The transdermal skin patches market in the United States is expected to reach a projected revenue of US$ 3,819.8 million by 2033. A compound annual growth rate of 7.6% is expected of the United States transdermal skin patches market from 2026 to 2033.
- MedTech
- Drug Delivery Devices
- Transdermal Skin Patches Market Outlook
- Drug Delivery Devices
Revenue, 2025 (US$M)
$2,139.0
Estimate, 2026 (US$M)
$2,283.8
Forecast, 2033 (US$M)
$3,819.8
CAGR, 2026 - 2033
7.6%
Global Market
Related Markets
Prism AI by Grand View ResearchFree to try
Ask a question about the transdermal skin patches market
Every figure cited from GVR research
U.S. transdermal skin patches market highlights
- The U.S. transdermal skin patches market generated a revenue of USD 2,139.0 million in 2025 and is expected to reach USD 3,819.8 million by 2033.
- The U.S. market is expected to grow at a CAGR of 7.6% from 2026 to 2033.
- In terms of segment, hospital pharmacies was the largest revenue generating end use in 2025.
- Online Pharmacies is the most lucrative end use segment registering the fastest growth during the forecast period.
Transdermal skin patches market data book summary
| Market revenue in 2025 | USD 2,139.0 million |
| Market revenue in 2033 | USD 3,819.8 million |
| Growth rate | 7.6% (CAGR from 2026 to 2033) |
| Largest segment | Hospital pharmacies |
| Fastest growing segment | Online Pharmacies |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hospital Pharmacies, Online Pharmacies, Retail Pharmacies |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Teikoku Pharma, Viatris Inc, Johnson & Johnson, Luye Pharma Group Ltd, Purdue Pharma, Henan Lingrui Pharmaceutical Co., Ltd, Samyang Biopharm USA, Hisamitsu Pharmaceutical Co Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 32.4% of the global transdermal skin patches market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. transdermal skin patches market is projected to lead the regional market in terms of revenue in 2033.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 3,819.8 million by 2033.
No credit card required*
Publish Date: Jun 12, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transdermal Skin Patches Market Scope
Transdermal Skin Patches Market segmentation & scope
Transdermal Skin Patches Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| Viatris Inc | View profile | 38,000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | www.viatris.com |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3,682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | www.hisamitsu.co.jp |
| Teikoku Pharma | View profile | 51-100 | San Jose, California, United States, North America | www.teikokuusa.com/ |
| Luye Pharma Group Ltd | View profile | 5,270 | Hongqiao Road 1438, 22/F, Gubei International Fortune Center II, Changning District, Shanghai, China, People's Republic of, 264003 | www.luye.cn |
| Purdue Pharma | View profile | 5001-10000 | Stamford, Connecticut, United States, North America | www.purduepharma.com |
| Henan Lingrui Pharmaceutical Co., Ltd | View profile | 1001-5000 | Xinyang, Henan, China, Asia | www.lingrui.com/ |
| Samyang Biopharm USA | View profile | 1-10 | Cambridge, Massachusetts, United States, North America | us.samyangbiopharm.com |
U.S. Transdermal Skin Patches Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Transdermal Skin Patches Market Outlook will help companies and investors design strategic landscapes.
Hospital Pharmacies was the largest segment with a revenue share of 42.12% in 2025.
Horizon Databook has segmented the U.S. transdermal skin patches market based on hospital pharmacies, online pharmacies, retail pharmacies covering the revenue growth of each sub-segment from 2021 to 2033.
- U.S. Transdermal Skin Patches Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- U.S. Transdermal Skin Patches Market Type Outlook (Revenue, USD Million , 2021-2033)
- Single-layer Drug-in-Adhesive
- Multi-layer Drug-in-Adhesive
- Other Types
- Matrix
- U.S. Transdermal Skin Patches Market Application Outlook (Revenue, USD Million , 2021-2033)
- Pain Relief
- Smoking Reduction and Cessation Aid
- Cardiovascular Disorders
- Hormonal Therapy
- Neurological Disorders
- Other Applications
Reasons to subscribe to Transdermal Skin Patches Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Transdermal Skin Patches Market Outlook databook
- Our clientele includes a mix of Transdermal Skin Patches Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. Transdermal Skin Patches Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.S. Transdermal Skin Patches Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
U.S. Transdermal Skin Patches Market, 2021-2033 (US$M)
U.S. transdermal skin patches market statistics, by end use, 2021-2033 (US$M)
